During the past decade, Florida Cancer Specialists South conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 41 clinical trials were completed, i.e. on average, 61.2% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 24 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Cancer Specialists South" #1 sponsor was "Hoffmann-La Roche" with 21 trials, followed by "SCRI Development Innovations, LLC" with 16 trials sponsored, "Genentech, Inc." with 6 trials sponsored, "Seagen Inc." with 6 trials sponsored and "Daiichi Sankyo, Inc." with 6 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Cancer Specialists South" #1 collaborator was "Novartis" with 6 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 4 trials as a collaborator, "GlaxoSmithKline" with 4 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator and "Merck Sharp & Dohme LLC" with 3 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Florida Cancer Specialists South" are "Breast Cancer" (8 trials), "Metastatic Breast Cancer" (5 trials), "Multiple Myeloma" (4 trials), "Bladder Cancer" (3 trials) and "Gastric Cancer" (3 trials). Many other conditions were trialed in "Florida Cancer Specialists South" in a lesser frequency.

Most popular intervention types in "Florida Cancer Specialists South" are "Drug" (81 trials), "Other" (8 trials), "Biological" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Atezolizumab" (14 trials), "Carboplatin" (9 trials), "Gemcitabine" (7 trials) and "Trastuzumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Florida Cancer Specialists South" are 77 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Florida Cancer Specialists South". undefined are not yet recruiting, 15 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Florida Cancer Specialists South, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Cancer Specialists South, 12 "Phase 1" clinical trials were conducted, 52 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".